(Q44346059)

English

The efficacy of trientine or ascorbate alone compared to that of the combined treatment with these two agents in familial amyotrophic lateral sclerosis model mice

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

The efficacy of trientine or ascorbate alone compared to that of the combined treatment with these two agents in familial amyotrophic lateral sclerosis model mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

amyotrophic lateral sclerosis

0 references

author name string

Seiichi Nagano

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Yuuichi Fujii

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Takeshi Yamamoto

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Mitsue Taniyama

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Kei Fukada

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Takehiko Yanagihara

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Saburo Sakoda

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Experimental Neurology

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

179

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

176-180

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Effects of an inhibitor of poly(ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

N-acetyl-L-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

Metal-induced hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

Chaperone-facilitated copper binding is a property common to several classes of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

Aberrant copper chemistry as a major mediator of oxidative stress in a human cellular model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

Subchronic toxicity of triethylenetetramine dihydrochloride in B6C3F1 mice and F344 rats

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

Biochemistry of metallothionein

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

Enhanced oxidative damage by the familial amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

Benefit of a combined treatment with trientine and ascorbate in familial amyotrophic lateral sclerosis model mice

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

Reduction of metallothioneins promotes the disease expression of familial amyotrophic lateral sclerosis mice in a dose-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

Stability of mutant superoxide dismutase-1 associated with familial amyotrophic lateral sclerosis determines the manner of copper release and induction of thioredoxin in erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

Vitamin C: newer insights into its biochemical functions

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

Ascorbate regulation and its neuroprotective role in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

Pharmacology of vitamin C

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900014-6

7 January 2021

Identifiers

10.1016/S0014-4886(02)00014-6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44346059&oldid=2109611339"